Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion type Assertion NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_head.
- NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion description "[Ovarian carcinomas (OC) arising in BRCA1 and BRCA2 mutation carriers demonstrate pronounced sensitivity to platinum-based therapy due to deficiency of double-strand break DNA repair.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_provenance.
- NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion evidence source_evidence_literature NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_provenance.
- NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion SIO_000772 25186150 NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_provenance.
- NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion wasDerivedFrom befree-2016 NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_provenance.
- NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_assertion wasGeneratedBy ECO_0000203 NP1216569.RANnFTUU_tU0CJtv94KRV5FevmSTvlHq-fgWdBhLOQwQk130_provenance.